Thu, Dec 18, 2014, 6:47 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Endocyte, Inc. (ECYT) Message Board

SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Interesting to see the increase in volume patterns today (11/24) from 2:30-close. ECYT did not track with NASDAQ or any other index during the same time period. There were no articles or releases to my knowledge that would have contributed to the clearly visible increase. This type of activity suggests to me that internal information is circling. Only time will tell.

  • Reply to

    CEO and CFO/COO Exercise Options

    by smiletothebank Nov 19, 2014 10:28 AM

    Well that is nice. Even nicer is today's close above $6.50. Granted volume wasn't super high and this is a slow week, but this could hopefully be start of another leg up.

  • Reply to

    CEO and CFO/COO Exercise Options

    by smiletothebank Nov 19, 2014 10:28 AM

    Jbaaaaaa looking at Form 4 now and definately listed listed as acquired not disposed.

    Sentiment: Strong Buy

  • Reply to

    Shorty in Aspen...

    by paintball_is_stellar Nov 21, 2014 7:10 PM

    Looking forward to your answer./p

  • Reply to

    Shorty in Aspen...

    by paintball_is_stellar Nov 21, 2014 7:10 PM

    Thank you for the info. I bought some of MACK but with what you're saying I think I'll try and get a buck or two out of it and move on. I agree with you in the sense that small bio rally is going on right now. At the same time, the whole market has had a late year rally. I think bio's are actually lagging considering the rest of the market. I'll look into AVAV a little more. Looks interesting.

    Finally, what'd you think of ECYT's last CC? I though it interesting that the lowest dosage of 1456 has stabilized the disease and that they are in cohort 4. What are your thoughts if they make it through 4 and into 5? I always appreciate you're pragmatic input. :)

  • Reply to

    Shorty in Aspen...

    by paintball_is_stellar Nov 21, 2014 7:10 PM

    Not a bio that i follow but after a quick look it doesn't excite me. Trading at a high market cap in relation to cash, debt and revs. I do see they got fast track status,that's a plus. If we can get a nice bear market rally in the bios going into year end, Mack and many others should get some nice action. And i am seeing some action moving in that direction. I generally refrain from recommending bios other than when i'm reasonably confident we're in the bull cycle. Way too dangerous at any other time. Just in the past 6 months i've seen many bios taken out and shot. That's a bad sign. Good luck

    Oh...i do like AVAV....it's a drone play and the valuation is reasonable. It's a low float stock so it can be volatile. Any bad news could trash it but over the long term i think it's a keeper. They announce earnings next week. I would NOT rush into it but keep it on the radar. Drones will be absolutely huge in the future. Much much bigger than everyone thinks currently.

  • whats your take on MACK? Looks like they got some big stuff there. Someone has likened them to PCYC. Interested in your thoughts. Thanks as always.

  • Reply to

    Jan 7.00 Calls

    by soozanie Nov 21, 2014 1:44 PM

    Someone is speculating that EC1456 will ignite this stock. It very well could. At these levels, stock is cheap.

  • just got an "alert". looks like someone just bought double the open in on the 7.00 call at .75.
    seems like the rocket ship fueling up. time will tell.

  • Reply to

    November Options

    by smiletothebank Nov 21, 2014 10:40 AM

    Yeah and watch it close under $6.50. Chances are it won't hold. Still waiting for it to close above $6.50 before we can see it move higher.

  • Reply to

    November Options

    by smiletothebank Nov 21, 2014 10:40 AM

    we have to wait like you say thats all nice day all longs

  • Reply to

    CEO and CFO/COO Exercise Options

    by smiletothebank Nov 19, 2014 10:28 AM

    jbaaa iam also here let say 3 lol

  • Over 300K volume in just a little over the first hour. Now why would we see this higher volume and PPS moving up the day options contracts mature? :)

    Sentiment: Strong Buy

  • Reply to

    CEO and CFO/COO Exercise Options

    by smiletothebank Nov 19, 2014 10:28 AM

    He who outlasts the trends will win. Glad to see we have outlasted thus far. :)

    Sentiment: Strong Buy

  • Reply to

    CEO and CFO/COO Exercise Options

    by smiletothebank Nov 19, 2014 10:28 AM

    Well I just thought to try and connect exercising options to a meaningful news event or stock price movement is quite a stretch. There could be so many reasons why they exercised options such as expiration dates, year end planning, pre-arranged agreement, exercise and sell, etc. I guess the one good thing you can draw is that they must feel there is not impending doom on the horizon lol. Now if an executive went out and bought 100,000 shares then maybe I would give that more credence to confidence in company.

    Seems like we are the only 2 left on this board. Not sure if that's a good or bad thing. My gut is it's a good thing as maybe less traders in this stock and maybe it can start to trade on it's own merits.

  • Reply to

    CEO and CFO/COO Exercise Options

    by smiletothebank Nov 19, 2014 10:28 AM

    Why is looking at the CEO and CFO exercising options silly? Since you question if they are holding or selling I'll let you do the work on this one; go back and find the last time Ellis/Sherman 1) sold stock and 2) exercised and then sold the same volume within a small amount of time. Now it has been routine for directors to exercise an option or stock gift only to sell them the same day. Again I am not looking back right now but I do not recall that scenario ever for Ellis or Sherman. Regarding personal financial gain; that is the entire point of a company giving its executives options?. The purchase price is fixed no matter the current market price so they financially gain every time they exercise an option. They know better than anyone else what is going on inside the company, so any decision they make to exercise options can always have some element of insider trading; its just the way it is. Both exercised days before the earnings call so I am pretty sure they knew what was going to be said during their call. Given your point of view; why would they exercise options prior to a conference call providing earnings and forward looking statements if that information could potentially increase the PPS. From your point of view they would be potentially setting themselves up for insider trading and you could argue a case that they already did? I take offense to the statement that I am trying to "Pump". I was merely stating facts that happened that anyone could find if they took the time read. I also stated that "correlation does not prove causation" with the events and their timing. People can make their own conclusions on the facts and their timing. I merely pointed out the coincidence with what history has shown and the timing with what happened and how it could potentially fit into one future scenario. I never claimed that is what would happen. Regarding volume this week; nothing expected to cause any large volume this week.

    Sentiment: Strong Buy

  • Reply to

    CEO and CFO/COO Exercise Options

    by smiletothebank Nov 19, 2014 10:28 AM

    You two make me smile.

    Sentiment: Strong Buy

  • Reply to

    CEO and CFO/COO Exercise Options

    by smiletothebank Nov 19, 2014 10:28 AM

    Now you are being plain silly. You don't even know if they are selling them or holding them yet. Also, if they knew the data and used it for personal financial gain they would be facing major insider trading issues. And given the small number of options exercised it's hardly noteworthy either way. Sorry, but I think your post is pure pumping which I expect better than from you.
    Either way, I agree that the stock will go higher as news comes out regarding final results. I expect we will stay under $6.50 this week unless volume really spikes. However, I do think better days are ahead. It seems that when biotechs are liked they tend to be overvalued like CMRX and RGLS. And the opposite is true as in the case of ECYT. I think fair value right now on ECYT given all the unknowns is $400-$500M given large cash position. So when it's selling under $300M it's too cheap and any news will drive it up nicely. So much is being discounted here..strong cash position with no debt, low share count with little dilution, multiple drugs in pipeline, and not to mention the low share price.

  • Just for those that don't keep up; Ron Ellis exercised 19,060 shares on 11/5 and Mike Sherman exercised 14,927 shares on 10/31. Ron Ellis has not exercised options many times, but the most recent prior to this event was at the beginning of March a few weeks before the TARGET data for NSCLC was released along with the positive opinions for 145. A significant value for the PPS increase that followed was attributed to NSCLC data. Correlation does not prove causation but perhaps the full OS data for TARGET is now in the hands of ECYT executives. It was expected by years end and if it takes a few weeks to organize the data for presentation; well the timing of these options exercises would put a release near mid to end of December when it was expected. Also, these options didn't expire for another 4-5 years. Anticipating good OS data which will help them decide how to proceed with next study with 145/1456. Get on the train now folks! (or at least by Monday after options contracts mature on Friday).

    Sentiment: Strong Buy

  • Reply to

    I hate using the word manipulated

    by jbaaaaa11 Nov 17, 2014 6:44 PM

    I donu0027t mind using it; it is what it is. Some say it can happen for some time; but I think this will all end prior to news release on OS data for TARGET and next cohort for 1456. Good things can be seen on the horizon. This was a manipulation to save face on gambling the wrong way prior to ESMO. If you believe in buying cheap and selling high then the time to buy is now. Every catalyst will cost more money to get in later.

    Sentiment: Strong Buy

ECYT
6.34-0.01(-0.08%)Dec 18 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.